ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • German ARIA Group - (Author)
  • Department of Paediatrics
  • Center for Rhinology and Allergology Wiesbaden
  • Ghent University
  • Stockholm University
  • Justus Liebig University Giessen
  • University of Tübingen
  • University of Bonn
  • University of Münster
  • Johannes Gutenberg University Mainz
  • Technical University of Munich
  • University of Freiburg
  • University of Göttingen
  • Augsburg University
  • Heidelberg University 
  • Gemeinschaftspraxis für Dermatologie
  • University of Lübeck
  • Friedrich-Alexander University Erlangen-Nürnberg
  • RWTH Aachen University
  • Asthma and Allergy Centre Leverkusen
  • TUD Dresden University of Technology
  • Evangelical Clinics of Bonn
  • Vorsitzender des Apothekenverbandes in Hessen
  • Fachkliniken Wangen
  • Leipzig University
  • Bundesgeschäftsführerin des Deutschen Allergie- und Asthmabundes DAAB
  • Dermatologische Gemeinschaftspraxis Wehrmann & Kolleginnen
  • Charité – Universitätsmedizin Berlin
  • University of Montpellier
  • University of Genoa
  • Vall d'Hebron University Hospital
  • University of South Florida
  • Medizinische Beratung Czarlewski
  • Abteilung Otorhinolaryngologie
  • Epilepsy Center Bethel
  • University Hospitals Leuven
  • Wrocław Medical University
  • Hospital Médica Sur
  • University of Barcelona
  • National and Kapodistrian University of Athens
  • University of Helsinki
Translated title of the contribution
ARIA Guideline 2019
Treatment of allergic rhinitis in the German health system

Details

Original languageGerman
Pages (from-to)43-72
Number of pages30
JournalAllergologie
Volume43
Issue number2
Publication statusPublished - 2020
Peer-reviewedYes

Keywords

ASJC Scopus subject areas

Keywords

  • Allergen-specific immunotherapy, Allergic asthma, Allergic diseases, Health care system, Integrated care pathway